Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Derfuss

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of the Neurological Sciences|June 6, 2013
Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneityA Waschbisch, M Atiya, C Schaub, et al.
The Journal of Biological Chemistry|July 21, 2001
Herpesvirus saimiri replaces ZAP-70 for CD3- and CD2-mediated T cell activationE Meinl, T Derfuss, R Pirzer, et al.
European Journal of Immunology|September 6, 2001
Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicityG Henning, M S Kraft, T Derfuss, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 15, 2020
The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosisT Derfuss, J Sastre-Garriga, X Montalban, et al.
European Journal of Neurology|February 26, 2020
Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatmentV von Wyl, B F Décard, P Benkert, et al.
Multiple Sclerosis and Related Disorders|July 18, 2018
Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosisY Naegelin, M Rasenack, M Andelova, et al.
Journal of the Neurological Sciences|April 11, 2021
Characteristics of improvements in balance control using vibro-tactile biofeedback of trunk sway for multiple sclerosis patientsJ H J Allum, H M Rust, N Lutz, et al.
Brain : a Journal of Neurology|June 16, 2001
Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune responseT Derfuss, R Gürkov, F Then Bergh, et al.
Brain : a Journal of Neurology|May 14, 2008
Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunityM Krumbholz, H Faber, F Steinmeyer, et al.
The European Respiratory Journal|June 3, 2010
Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensingN Sommer, O Pak, S Schörner, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of the Neurological Sciences|June 6, 2013
Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneityA Waschbisch, M Atiya, C Schaub, et al.
The Journal of Biological Chemistry|July 21, 2001
Herpesvirus saimiri replaces ZAP-70 for CD3- and CD2-mediated T cell activationE Meinl, T Derfuss, R Pirzer, et al.
European Journal of Immunology|September 6, 2001
Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicityG Henning, M S Kraft, T Derfuss, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 15, 2020
The ACROSS study: Long-term efficacy of fingolimod in patients with relapsing-remitting multiple sclerosisT Derfuss, J Sastre-Garriga, X Montalban, et al.
European Journal of Neurology|February 26, 2020
Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatmentV von Wyl, B F Décard, P Benkert, et al.
Multiple Sclerosis and Related Disorders|July 18, 2018
Shortening the washout to 4 weeks when switching from natalizumab to fingolimod and risk of disease reactivation in multiple sclerosisY Naegelin, M Rasenack, M Andelova, et al.
Journal of the Neurological Sciences|April 11, 2021
Characteristics of improvements in balance control using vibro-tactile biofeedback of trunk sway for multiple sclerosis patientsJ H J Allum, H M Rust, N Lutz, et al.
Brain : a Journal of Neurology|June 16, 2001
Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune responseT Derfuss, R Gürkov, F Then Bergh, et al.
Brain : a Journal of Neurology|May 14, 2008
Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunityM Krumbholz, H Faber, F Steinmeyer, et al.
The European Respiratory Journal|June 3, 2010
Mitochondrial cytochrome redox states and respiration in acute pulmonary oxygen sensingN Sommer, O Pak, S Schörner, et al.
Pageof 3